Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 3

1(25.0%)

4Total

N/A(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06360783Completed

COVID-19 Quick Start - Test and Treat in Africa

Role: collaborator

NCT05886530Active Not Recruiting

DSD Models at South Africa Sentinel Sites

Role: collaborator

NCT06087315Recruiting

Evaluation of a Multi-country Medical Oxygen Program

Role: collaborator

NCT06444633Not ApplicableRecruiting

The Impact of Pre-emptive Home Delivery of ORS + Zinc on Treatment for Child Diarrhea

Role: collaborator

NCT04037332Completed

Monitoring of Molecular Markers of Artemisinin Resistance Through Repeated Cross-sectional Assessments in DR Congo, Nigeria and Uganda

Role: collaborator

NCT03810014Not ApplicableCompleted

Malaria Diagnostic Testing and Conditional Subsidies to Target ACTs in the Retail Sector: the TESTsmART Trial AIM 1

Role: collaborator

NCT02610400Phase 3Completed

Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in Namibia

Role: collaborator

NCT01652365Not ApplicableCompleted

Feasibility and Impact of Malaria Rapid Diagnostic Tests in the African Retail Sector

Role: collaborator

All 8 trials loaded